Study finds Twitter mentions of pneumonia up in Europe ahead of COVID-19 outbreak
The study compared mentions of  pneumonia in the winter of 2019-2020 to those of previous winters.  (Source: mobihealthnews)
Source: mobihealthnews - January 27, 2021 Category: Information Technology Source Type: news

COVID-19 warnings were on Twitter well before the outbreak of the pandemic
(IMT School for Advanced Studies Lucca) A new study of researchers at IMT School for Advanced Studies Lucca, published in Scientific Reports, has identified tracks of increasing concern about pneumonia cases on posts published on Twitter in seven countries, between the end of 2019 and the beginning of 2020. The analysis of the posts shows that the " whistleblowing " came precisely from the geographical regions where the primary outbreaks later developed. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 25, 2021 Category: Infectious Diseases Source Type: news

Can CT provide a better map of breast density?
An international research team used dozens of CT images to map breast density...Read more on AuntMinnie.comRelated Reading: Coding changes that will impact radiology in 2021 Case study: Breast CT uncovers COVID-19 pneumonia Izotropic lands breast density measurement patent Dedicated breast CT shows promise for cancer screening Can AI enhance the utility of breast conebeam CT? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 21, 2021 Category: Radiology Source Type: news

Study finds genetic clues to pneumonia risk and COVID-19 disparities
(Vanderbilt University Medical Center) Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 21, 2021 Category: Infectious Diseases Source Type: news

What Are Potential Problems of Congenital Lung Malformations?
Discussion Congenital lung malformations (CLM) are commonly identified with prenatal ultrasound and occur in ~1:2400 live births. The natural history shows that lesions may remain the same, enlarge or appear to disappear. There is a wide-range of clinical manifestations. Patients may be asymptomatic or symptomatic at birth and often develop symptoms later. The overall natural history is difficult to ascertain as there are fewer studies done in older children and adults. Those that are done often lack a good denominator by which to judge the incidence or prevalence. Resection is carried out usually if a patient is symptomat...
Source: PediatricEducation.org - January 18, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 15, 2021 (HORSHAM, Pa.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1] DARZALEX FASPRO® is the first and only FDA-approved treatment for patients with this blood cell disorder that is associated with the production of an abnormal protein, which leads to th...
Source: Johnson and Johnson - January 16, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
(University of Cambridge) Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 15, 2021 Category: Infectious Diseases Source Type: news

Fewer Children Died in 2020, Despite the Pandemic. Experts Are Trying to Figure Out Why
Since the global pandemic began, one of the grimmer features of daily life has been watching the coronavirus death count tick up and up as the months have gone by. With so much unnecessary death in 2020, it’s surprising that in many countries, at least according to preliminary numbers, there was one significant group that actually saw its death rates fall: children. Data from the Human Mortality Database, a research project run by a global team of demographers, suggest that COVID-19 did not reverse years-long declines in child mortality, despite a mortality surge in the general population. Demographers, pediatricians...
Source: TIME: Health - January 14, 2021 Category: Consumer Health News Authors: Emily Barone Tags: Uncategorized COVID-19 Source Type: news

Large and Small Cerebral Vessel Involvement in Severe COVID-19 Large and Small Cerebral Vessel Involvement in Severe COVID-19
This case series details the neurological workups of 8 patients with severe COVID-19 pneumonia with subsequent neurological complications.Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 13, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Research Shows Why COVID Pneumonia Is More Deadly
People using these medications for diabetes are at risk of a potentially fatal complication called diabetic ketoacidosis (DKA), and it now appears that risk increases even more if they become sick with COVID-19 (Source: WebMD Health)
Source: WebMD Health - January 12, 2021 Category: Consumer Health News Source Type: news

Research Shows Why COVID Pneumonia Is More Deadly
Unlike regular pneumonia, COVID-19 pneumonia spreads like many "wildfires" throughout the lungs, researchers say. (Source: WebMD Health)
Source: WebMD Health - January 12, 2021 Category: Consumer Health News Source Type: news

Research Reveals Why COVID Pneumonia Is More Deadly
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - January 12, 2021 Category: Respiratory Medicine Tags: Family Medicine, Infections, Pulmonology, Research, News, Source Type: news

Research Reveals Why COVID-19 Pneumonia Is More Deadly
TUESDAY, Jan. 12, 2021 -- Unlike regular pneumonia, COVID-19 pneumonia spreads like many " wildfires " throughout the lungs, researchers say. This may explain why COVID-19 pneumonia lasts longer and causes more harm than typical pneumonia, according... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 12, 2021 Category: General Medicine Source Type: news

Interim Position Statement: Interleukin-6 inhibitors (tocilizumab or sarilumab) for patients admitted to ICU with COVID-19 pneumonia (adults), MHRA (issued 8th January 2021)
The REMAP-CAP platform trial has reported survival and time to recovery benefits for tocilizumab or sarilumab. Clinicians should consider prescribing IV tocilizumab (sarilumab an alternative if available) following the criteria defined in this interim position statement. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 11, 2021 Category: Consumer Health News Source Type: news

Why COVID-19 pneumonia lasts longer, causes more damage than typical pneumonia
(Northwestern University) COVID pneumonia is significantly different from pneumonia caused by other causes, reports a new study in Nature. It shows how hijacks the lungs' own immune cells and uses them to spread across the lung over weeks. The infection leaves damage in its wake and fuels the fever, low blood pressure and damage to the kidneys, brain, heart and other organs in patients with COVID-19. Scientists discovered a target for treating COVID pneumonia and a clinical trial is underway at Northwestern. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 11, 2021 Category: Infectious Diseases Source Type: news

Laws Promoting Flu Shot for Hospital Workers Can Cut Deaths
2.5 percent drop seen in monthly pneumonia, flu mortality rates with implementation of state laws requiring hospitals to offer flu shot (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - January 8, 2021 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Laws Promoting Flu Shot for Hospital Workers Can Cut Deaths
FRIDAY, Jan. 8, 2021 -- State laws promoting hospital worker vaccination against influenza may be effective for reducing monthly pneumonia and influenza mortality rates, especially among the elderly, according to a study published online Jan. 5 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 8, 2021 Category: Pharmaceuticals Source Type: news

Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19. Nutrients 12(12).
There are limited proven therapies for COVID-19. Vitamin C's antioxidant, anti-inflammatory and immunomodulating effects make it a potential therapeutic candidate, both for the prevention and amelioration of COVID-19 infection, and as an adjunctive therapy in the critical care of COVID-19. This literature review focuses on vitamin C deficiency in respiratory infections, including COVID-19, and the mechanisms of action in infectious disease, including support of the stress response, its role in preventing and treating colds and pneumonia, and its role in treating sepsis and COVID-19. The evidence to date indicates that oral...
Source: Current Awareness Service for Health (CASH) - January 8, 2021 Category: Consumer Health News Source Type: news

How Do I Know if My Child has Pneumonia?
Title: How Do I Know if My Child has Pneumonia?Category: Diseases and ConditionsCreated: 1/8/2021 12:00:00 AMLast Editorial Review: 1/8/2021 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - January 8, 2021 Category: Pediatrics Source Type: news

If Covid-19 is Primarily a ‘First World’ Virus, Why is the Global South in Lockdown?
A lockdown closer home. Secretary-General Antonio Guterres walking the empty corridors of the UN Secretariat building in New York in 2020. Credit: United NationsBy Darini Rajasingham-SenanayakeCOLOMBO, Sri Lanka, Jan 7 2021 (IPS) The currently available Covid-19 vaccines have been authorized for ‘emergency use ‘in Europe and North America. This is due to an apparent spike in Covid-19 flu cases in the northern hemisphere as winter advances. Highly advertised vaccines are being produced and rolled out at ‘warped speed’ by powerful pharmaceutical and bio-technology companies headquartered in Euro-Ameri...
Source: IPS Inter Press Service - Health - January 7, 2021 Category: International Medicine & Public Health Authors: Darini Rajasingham-Senanayake Tags: Aid Development & Aid Editors' Choice Featured Global Headlines Health Human Rights IPS UN: Inside the Glasshouse Population Poverty & SDGs TerraViva United Nations Source Type: news

What are the Three Major Causes of Pneumonia?
Title: What are the Three Major Causes of Pneumonia?Category: Diseases and ConditionsCreated: 1/6/2021 12:00:00 AMLast Editorial Review: 1/6/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 6, 2021 Category: Respiratory Medicine Source Type: news

Study: Mandating flu shots for hospital workers reduces viral spread, deaths
States with laws mandating flu shots for hospital workers saw reductions in deaths from influenza and pneumonia across their populations, a study published Friday by the Annals of Internal Medicine found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 4, 2021 Category: Consumer Health News Source Type: news

Care bundles for improving outcomes in patients with COVID19 or related conditions in intensive care a rapid scoping review, Cochrane Library
Main results We included 21 studies and identified three ongoing studies. The studies were of variable designs and included a systematic review of standardised approaches to caring for critically ill patients in ICU, including but not exclusive to care bundles (1 study), a randomised trial (1 study), prospecti ve and retrospective cohort studies (4 studies), before and after studies (7 studies), observational quality improvement reports (4 studies), case series/case reports (3 studies) and audit (1 study). The studies were conducted in eight countries, most commonly China (5 studies) and the USA (4 studie s), were publis...
Source: Current Awareness Service for Health (CASH) - January 4, 2021 Category: Consumer Health News Source Type: news

Oral amoxicillin optimal choice for chest-indrawing pneumonia in young children in Nigeria
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - January 1, 2021 Category: Drugs & Pharmacology Source Type: news

World prepares for muted New Year's Eve under Covid shadow
Britons urged to stay home; France puts 100,000 police out on patrol; Merkel laments hardest year; Times Square closed to publicSee all our coronavirus coverageMillions of people around the world are preparing for a New Year ’s Eve like no other – with lockdowns, restrictions and curfews in place in dozens of countries in an attempt to stem the spread of Covid-19 before vaccination drives start to take effect.New Year ’s Eve marks one year since the World Health Organization first mentioned a mysterious pneumonia inChina later identified as Covid-19, which went on in 2020 to kill more than 1.79 million pe...
Source: Guardian Unlimited Science - December 31, 2020 Category: Science Authors: Guardian staff and agencies Tags: Coronavirus UK news US news France Germany Australia news Europe Infectious diseases Science World news Source Type: news

Sustained cellular immune dysregulation in individuals recovering from COVID-19
COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path. Many infected patients remain asymptomatic or have mild symptoms. Others, especially those with comorbidities, can develop severe clinical disease with atypical pneumonia and multiple system organ failure. (Source: World Pharma News)
Source: World Pharma News - December 29, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Don ’t Let the Pandemic Stop Your Shots
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That ’s not wise, health experts say. (Source: NYT Health)
Source: NYT Health - December 28, 2020 Category: Consumer Health News Authors: Paula Span Tags: your-feed-science Whooping Cough Shingles (Disease) Diphtheria Coronavirus (2019-nCoV) Influenza Elderly Epidemics Drugs (Pharmaceuticals) Pneumonia your-feed-healthcare Vaccination and Immunization Hepatitis Tetanus Minorities Source Type: news

Vardhan launches India's first indigenously developed pneumococcal vaccine 'Pneumosil'
During clinical trials, Pneumosil was found to be safe and effective in the prevention of pneumonia and based on which Pneumosil has been licensed by the Drugs Controller General of India in July 2020 after approval from subject expert committee (SEC), he said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 28, 2020 Category: Pharmaceuticals Source Type: news

Point of View: A first-hand account from an Alberta ICU during Christmas
The board listing the patients and their diagnosis summarized the story of his night. Some said hypoxic respiratory failure. Others said pneumonia. Others said COVID-19. One simply read shortness of breath. It's funny how many ways we’ve come to label this illness. (Source: CBC | Health)
Source: CBC | Health - December 25, 2020 Category: Consumer Health News Tags: News/Canada/Edmonton Source Type: news

Serum Institute develops first indigenous vaccine against pneumonia; to be launched next week
India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm. (Source: The Economic Times)
Source: The Economic Times - December 24, 2020 Category: Consumer Health News Source Type: news

COVID-19: First 10 days after hospital discharge are most dangerous
A new study found that 14% of COVID-19 patients were rehospitalized or died within 10 days of being discharged compared to 9.7% of pneumonia patients and 8.8% of heart failure patients (Source: the Mail online | Health)
Source: the Mail online | Health - December 23, 2020 Category: Consumer Health News Source Type: news

Ultrasound outperforms x-ray for neonatal pneumothorax
Lung ultrasound scans outperformed chest x-rays for diagnosing neonatal pneumothorax...Read more on AuntMinnie.comRelated Reading: Deep-learning algorithm detects free air on CT images CT helps diagnose pediatric handlebar injury AI differentiates COVID-19 from other pneumonia AI may help improve sensitivity of ED chest x-ray reads AI algorithm identifies pneumothorax on chest x-rays (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 23, 2020 Category: Radiology Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS Patient Care - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS Administration and Leadership - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS Latest News - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS: Journal of Emergency Medical Services News - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS Operations - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS Special Topics - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

RedHill's phase 2/3 COVID-19 study of opaganib passes second DSMB review
(RedHill Biopharma) RedHill Biopharma Ltd. (Nasdaq: RDHL), a specialty biopharmaceutical company, today announced that the global Phase 2/3 study with orally-administered opaganib (Yeliva ® , ABC294640) in patients hospitalized with severe COVID-19 pneumonia has received a second unanimous recommendation to continue, following a second independent Data Safety Monitoring Board (DSMB) safety review. The DSMB's recommendation is based on an analysis of unblinded safety data from the first 155 patients treated for 14 days. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 22, 2020 Category: Infectious Diseases Source Type: news

Underestimating the Coronavirus...Until It Was Too Late Underestimating the Coronavirus...Until It Was Too Late
When Chinese officials revealed that their pneumonia outbreak was caused by another new coronavirus, Asian countries hit hard by SARS knew what they had to do. The US learned all the wrong lessons.Kaiser Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - December 21, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Position statement: Use of investigational immunomodulatory medicines for COVID-19 Interim support for UK hospital clinicians, RCP
Key messages • A subset of patients with COVID-19 may experience an exaggerated hyperinflammatory response • COVID-19 associated hyperinflammation predominantly involves the lung however may progress to secondary haemophagocytic lymphohistocytosis (sHLH) which is a systemic and multi-organ condition with significant morbidity and mortality • CTAG strongly recommends systemic corticosteroids for patients who fit definitions of WHOdefined severe or critical COVID-19, or in patients who otherwise have a new oxygen requirement • CTAG also recommends not to use corticosteroid therapy in patients with...
Source: Current Awareness Service for Health (CASH) - December 21, 2020 Category: Consumer Health News Source Type: news

'The coughing would not stop': MP talks of 'unbearable pain' of Covid
Labour shadow minister Yasmin Qureshi speaks of slow recovery after hospital admissionCoronavirus – latest updatesSee all our coronavirus coverageA shadow minister who became the first female MP to be admitted to hospital with Covid-19 has described the “unbearable pain” caused by coughing fits and pneumonia as the disease took hold.Yasmin Qureshi, the Labour MP for Bolton South East and a shadow minister for international development, said she was left “anxious and concerned” after being taken by ambulance to her local hospital in October.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 21, 2020 Category: Science Authors: Rajeev Syal Tags: Coronavirus Infectious diseases Science Labour Politics UK news Source Type: news

Pneumolysis: High altitude specialists explain lung destruction caused by COVID-19
(Bentham Science Publishers) According to the scientific paper, COVID-19's hypoxemia (low oxygen tension in the blood) can hardly be handled by ventilators and should not be considered as pneumonia or treated as a SARS (severe acute respiratory syndrome). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 21, 2020 Category: International Medicine & Public Health Source Type: news

Tocilizumab Cuts Progression to Ventilation or Death in COVID - 19
But death from any cause by day 28 in those hospitalized with COVID - 19 pneumonia did not differ for tocilizumab versus placebo (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - December 18, 2020 Category: Respiratory Medicine Tags: Infections, Nursing, Pharmacy, Pulmonology, Critical Care, Emergency Medicine, Journal, Source Type: news

Cadmium Burden Linked to Mortality From Flu, Pneumonia
Risk for related mortality increased with urinary cadmium in the 80th versus the 20th percentile in whole population, never smokers in NHANES - III (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - December 18, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Pulmonology, Journal, Source Type: news

Tocilizumab Cuts Progression to Ventilation or Death in COVID-19
FRIDAY, Dec. 18, 2020 -- Tocilizumab reduces the risk for progression to ventilation or death among hospitalized patients with COVID-19 pneumonia, according to a study published online Dec. 18 in the New England Journal of Medicine. Carlos Salama,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 18, 2020 Category: Pharmaceuticals Source Type: news

Cadmium Burden Linked to Mortality From Flu, Pneumonia
FRIDAY, Dec. 18, 2020 -- Cadmium burden is associated with increased mortality from influenza or pneumonia in U.S. adults, according to a study published online Dec. 16 in Environmental Health Perspectives. Sung Kyun Park, Sc.D., M.P.H., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 18, 2020 Category: Pharmaceuticals Source Type: news

New study links cadmium to more severe flu, pneumonia infections
(University of Michigan) High levels of cadmium, a chemical found in cigarettes and in contaminated vegetables, are associated with higher death rates in patients with influenza or pneumonia--and may increase the severity of COVID-19 and other respiratory viruses, according to a new study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 16, 2020 Category: Infectious Diseases Source Type: news

An atlas of S. pneumoniae and host gene expression during colonization and disease
(University of Alabama at Birmingham) The bacteria Streptococcus pneumoniae colonizes the nasopharynx and can cause pneumonia. Then, it can spread to the bloodstream and cause organ damage. To understand how this pathogen adapts to different locations in the body, and also how the host responds to the microbe, researchers have measured bacterial and host gene expression at five different sites in a mouse model -- the nasopharynx, lungs, blood, heart and kidneys -- using three genetically different strains of S. pneumoniae. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 16, 2020 Category: Infectious Diseases Source Type: news

Study uncovers two phases of infection in patients with severe COVID-19 pneumonia
(Massachusetts General Hospital) To analyze SARS-CoV-2 at the tissue level, scientists examined lung specimens from 24 patients who succumbed to COVID-19. The analyses revealed two phases of infection in the patients: an early phase defined by high levels of virus in the lungs, and a later phase in which the virus is no longer present, but the damage to the lungs is too severe for recovery. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 16, 2020 Category: Infectious Diseases Source Type: news